https://orcid.org/0000-0001-5551-1340
References
- Walsh JS, Newman C, Eastell R. Heart drugs that affect bone. Trends Endocrinol Metab. 2012;23(4):163–168.
- Fiordellisi W, White K, Schweizer M. A systematic review and meta-analysis of the association between vitamin K antagonist use and fracture. J Gen Intern Med. 2019;34(2):304–311.
- Szulc P, Chapuy MC, Meunier PJ, et al. Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J Clin Invest. 1993;91(4):1769–1774.
- Lau WC, Chan EW, Cheung CL, et al. Association between dabigatran vs warfarin and risk of osteoporotic fractures among patients with nonvalvular atrial fibrillation. JAMA. 2017;317(11):1151–1158.
- Norby FL, Bengtson LGS, Lutsey PL, et al. Comparative effectiveness of rivaroxaban versus warfarin or dabigatran for the treatment of patients with non-valvular atrial fibrillation. BMC Cardiovasc Disord. 2017;17(1):238.
- Gu ZC, Zhou LY, Shen L, et al. Non-vitamin K antagonist oral anticoagulants vs. warfarin at risk of fractures: a systematic review and meta-analysis of randomized controlled trials. Front Pharmacol. 2018;9:348.
- Binding C, Olesen JB, Abrahamsen B, et al. Osteoporotic fractures in patients with atrial fibrillation treated with conventional versus direct anticoagulants. J Am Coll Cardiol. 2019;74(17):2150–2158.
- Lutsey PL, Norby FL, Ensrud KE, et al. Association of anticoagulant therapy with risk of fracture among patients with atrial fibrillation. JAMA Intern Med. 2020;180(2):245–253.
- Huang HK, Liu PP, Hsu JY, et al. Fracture risks among patients with atrial fibrillation receiving different oral anticoagulants: a real-world nationwide cohort study. Eur Heart J. 2020;41(10):1100–1108.
- Huang HK, Yeh JI, Loh CH. Hip fracture risk in patients with atrial fibrillation receiving oral anticoagulants: a meta-analysis based on current observational studies. Eur Heart J. 2020;41(30):2919-2920.
- Sugiyama T. Anticoagulant therapy and hip fracture risk: a possible involvement of physical activity. J Am Coll Cardiol. 2020;75(8):987.
- Sugiyama T. Hip fracture risk in patients with atrial fibrillation receiving oral anticoagulants. Eur Heart J. 2020;41(30):2918.
- Gage BF. Warfarin-induced fractures in atrial fibrillation? J Am Coll Cardiol. 2019;74(17):2159–2161.
- Dunn A. In AF, DOACs were linked to lower risk for osteoporotic fractures at 2 years compared with VKAs. Ann Intern Med. 2020;172(6):JC35.
- Eastell R, Rosen CJ, Black DM, et al. Pharmacological management of osteoporosis in postmenopausal women: an Endocrine Society* clinical practice guideline. J Clin Endocrinol Metab. 2019;104(5):1595–1622.